Geisinger Clinic

geisinger.org

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

121

Active

16

Phase 3

1

Total enrollment

1,393,649

Pipeline matrix

Showing 8 of 8 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Colchicine 1.8 mg (loading dose) + Dextrose Oral Placebo1
Colchicine 1.8 mg + 0.6 mg1
Dextrose Oral Placebo1
mineral trioxide aggregate1
Topical Timolol1
Normal Saline1
Amoxicillin1
Liposomal bupivacaine2

Next readouts

  • 2025-12-31
  • 2026-01-01
  • 2026-08-01
  • 2026-12-31
  • 2028-07

Top conditions

  • Obesity10
  • Health Promotion8
  • Health Behavior6
  • Influenza5
  • Emergency Service, Hospital4
  • Hypertension4
  • Pediatric Dentistry3
  • Behavioral Intervention3

Frequently asked questions about Geisinger Clinic

How many clinical trials does Geisinger Clinic have on ClinicalTrials.gov?
Geisinger Clinic is listed as the lead sponsor on 121 clinical trials in ClinicalTrials.gov, 16 of which are currently active (recruiting, enrolling, or ongoing).
How many of Geisinger Clinic's trials are in Phase 3?
1 of Geisinger Clinic's trials are in Phase 3, spread across 8 active drug programs.
What therapeutic areas does Geisinger Clinic focus on?
Geisinger Clinic's most-studied conditions on ClinicalTrials.gov are Obesity, Health Promotion, Health Behavior, Influenza, Emergency Service, Hospital.
When are Geisinger Clinic's next clinical trial readouts?
Geisinger Clinic has 5 upcoming primary-completion readouts tracked here; the soonest is “Liposomal Bupivacaine and Transoral Robotic Surgery”, expected around 2025-12-31.